ViiV Healthcare was established to take a fresh approach to the challenge of HIV. We set ourselves one mission - to leave no person living with HIV behind.

Our culture:

  • Ambitious for patients to deliver what matters better and faster
  • Accountable for impact with clear ownership to support and succeed
  • Do the right thing with integrity and care because people count on us

Explore our stories to see how we bring these values and expectations to life through partnership and innovation.

OUR COMMITMENT TO INCLUSION AND DIVERSITY

Living our mission of leaving no person living with HIV behind means keeping inclusion and diversity at the heart of everything we do - from our breakthrough innovation, to our diverse portfolio of medicines as well as the work we do to partner with HIV communities.

Having a diverse team and a truly inclusive culture where we’re all able to be ourselves and feel like we belong will make us an even stronger team, better able to perform as a business and deliver on our mission to leave no person living with HIV behind.

We’ve made good progress – reviewing our recruitment and selection processes, delivering new inclusion training, and launching a development programme for ethnically diverse employees and we want to achieve even more. That is why we are proud to be an important part of the aspirational targets announced by our majority shareholder, GSK, to ensure we have the focus we need to do even better.

Inclusion & Diversity Commitments
Disability
 1. As a member of the Valuable 500, deliver against its objectives
Gender
 2. Globally, at least 45% female representation in senior roles by end of 2025
LGBT+ 3. Be recognised in global LGBT+ indices
Race & Ethnicity

4. In the US: at least 30% ethnically diverse leaders in our VP and above roles by the end of 2025

5. In the UK: at least 18% ethnically diverse leaders in our VP and above roles by the end of 2025

At the end of 2021, we reported strong growth in the diversity of our leadership and are on track overall to achieve our aspirations. Click here to find out more about the progress we are making and how we, along with our majority shareholder GSK, are working to foster a more inclusive environment.

NP-GBL-HVX-COCO-220011 March 2024.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.